Fabrizio De Benedetti

23.3k total citations · 4 hit papers
304 papers, 11.7k citations indexed

About

Fabrizio De Benedetti is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Fabrizio De Benedetti has authored 304 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Hematology, 117 papers in Immunology and 85 papers in Molecular Biology. Recurrent topics in Fabrizio De Benedetti's work include Autoimmune and Inflammatory Disorders Research (133 papers), Adolescent and Pediatric Healthcare (52 papers) and Inflammasome and immune disorders (52 papers). Fabrizio De Benedetti is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (133 papers), Adolescent and Pediatric Healthcare (52 papers) and Inflammasome and immune disorders (52 papers). Fabrizio De Benedetti collaborates with scholars based in Italy, United States and United Kingdom. Fabrizio De Benedetti's co-authors include Angelo Ravelli, Alberto Martini, Claudia Bracaglia, Giusi Prencipe, Alexei A. Grom, Margherita Massa, Luisa Bracci‐Laudiero, Ivan Caiello, Patrizia Pignatti and Antonella Insalaco and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Fabrizio De Benedetti

279 papers receiving 11.4k citations

Hit Papers

Drug Retention Rate and P... 2019 2026 2021 2023 2019 2020 2020 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
    2019 528 citations Antonella Insalaco, Maria Alessio et al. profile →
  2. On the Alert for Cytokine Storm: Immunopathology in COVID‐19
    2020 475 citations Alexei A. Grom, Angelo Ravelli et al. profile →
  3. Translating IL-6 biology into effective treatments
    2020 441 citations Fabrizio De Benedetti et al. Nature Reviews Rheumatology profile →
  4. Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
    2020 311 citations Franco Locatelli, Fabrizio De Benedetti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabrizio De Benedetti Italy 55 4.1k 4.0k 3.2k 1.9k 1.7k 304 11.7k
Rolando Cimaz Italy 56 3.2k 0.8× 2.8k 0.7× 2.5k 0.8× 3.7k 2.0× 2.3k 1.4× 364 11.6k
Akihiro Yachie Japan 50 2.1k 0.5× 4.0k 1.0× 4.4k 1.4× 743 0.4× 1.2k 0.7× 356 10.7k
Norihiro Nishimoto Japan 46 2.6k 0.6× 3.9k 1.0× 2.2k 0.7× 3.6k 2.0× 848 0.5× 132 11.0k
Kazuyuki Yoshizaki Japan 53 1.9k 0.5× 4.4k 1.1× 2.7k 0.8× 2.6k 1.4× 902 0.5× 143 12.2k
Naoyuki Kamatani Japan 58 1.3k 0.3× 2.5k 0.6× 5.3k 1.7× 4.4k 2.4× 1.6k 0.9× 344 13.5k
Donato Rigante Italy 49 1.5k 0.4× 1.7k 0.4× 3.2k 1.0× 1.7k 0.9× 1.4k 0.9× 330 7.7k
Pål Aukrust Norway 67 937 0.2× 5.2k 1.3× 5.2k 1.6× 1.0k 0.5× 2.5k 1.5× 479 18.7k
Thor Ueland Norway 66 750 0.2× 4.0k 1.0× 5.6k 1.8× 1.1k 0.6× 3.1k 1.8× 563 19.4k
Luca Cantarini Italy 49 1.7k 0.4× 2.1k 0.5× 3.1k 1.0× 2.8k 1.5× 807 0.5× 357 8.6k
Guido Valesini Italy 64 2.7k 0.6× 4.4k 1.1× 2.3k 0.7× 8.2k 4.4× 2.1k 1.3× 561 16.3k

Countries citing papers authored by Fabrizio De Benedetti

Since Specialization
Citations

This map shows the geographic impact of Fabrizio De Benedetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio De Benedetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio De Benedetti more than expected).

Fields of papers citing papers by Fabrizio De Benedetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizio De Benedetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio De Benedetti. The network helps show where Fabrizio De Benedetti may publish in the future.

Co-authorship network of co-authors of Fabrizio De Benedetti

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio De Benedetti. A scholar is included among the top collaborators of Fabrizio De Benedetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio De Benedetti. Fabrizio De Benedetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benedetti, Fabrizio De & Aziz Shaibani. (2025). The Relationship Between Placebo, Nocebo, and Cardiovascular Disease. Cardiology Clinics. 44(2). 159–165.
2.
Locci, Federica, Martin Peifer, Antonella Montinaro, et al.. (2025). STING induces ZBP1-mediated necroptosis independently of TNFR1 and FADD. Nature. 647(8090). 735–746. 4 indexed citations
3.
Marasco, Emiliano, Claudia Bracaglia, Pietro Merli, et al.. (2024). P101 Anti-CD19 CAR-T cell therapy for refractory childhood-onset systemic lupus erythematosus. SHILAP Revista de lepidopterología. A113.1–A113. 6 indexed citations
4.
Gianviti, Alessandra, et al.. (2024). Monogenic systemic lupus erythematosus onset in a 13-year-old boy with Noonan like-syndrome: a case report and literature review. Pediatric Rheumatology. 22(1). 17–17. 4 indexed citations
5.
6.
Bracaglia, Claudia, Manuela Pardeo, Giulia Marucci, et al.. (2023). AB1429 EMAPALUMAB TREATMENT FOLLOWED BY HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS COMPLICATED BY RECURRENT MACROPHAGE ACTIVATION SYNDROME. Annals of the Rheumatic Diseases. 82. 1943–1944.
7.
Raffaelli, L., Federica Colombo, Federico Calesella, et al.. (2023). Predicting unipolar and bipolar depression using inflammatory markers, neuroimaging and neuropsychological data: a machine learning study. European Psychiatry. 66(S1). S621–S621.
8.
Álvarez, Patrícia, Chiara Passarelli, Virginia Messia, et al.. (2023). POS0135 GENETICAL AND PHENOTYPICAL FINDINGS OF CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 82. 287–287. 1 indexed citations
9.
10.
11.
Benedetti, Fabrizio De, Giusi Prencipe, Claudia Bracaglia, Emiliano Marasco, & Alexei A. Grom. (2021). Targeting interferon-γ in hyperinflammation: opportunities and challenges. Nature Reviews Rheumatology. 17(11). 678–691. 86 indexed citations
12.
Cimmino, Marco A., Francesca Barbieri, Stefano Bombardieri, et al.. (2020). <p>Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study</p>. Biologics. Volume 14. 13–21. 2 indexed citations
13.
Stellacci, Emilia, Gian Marco Moneta, Alessandro Bruselles, et al.. (2019). The activating p.Ser466Arg change in STAT1 causes a peculiar phenotype with features of interferonopathies. Clinical Genetics. 96(6). 585–589. 10 indexed citations
14.
Minnone, Gaetana, Marzia Soligo, Ivan Caiello, et al.. (2017). ProNGF-p75NTR axis plays a proinflammatory role in inflamed joints: a novel pathogenic mechanism in chronic arthritis. RMD Open. 3(2). e000441–e000441. 18 indexed citations
15.
Koné‐Paut, Isabelle, Michaël Hofer, Susanne M. Benseler, et al.. (2017). Improvement of Disease Activity in Patients with Colchicine-Resistant FMF, Hids/Mkd and TRAPS Assessed By Autoinflammatory Disease Activity Index (AIDAI): Results from a Randomized Phase III Trial. Arthritis & Rheumatism. 2 indexed citations
16.
Malattia, Clara, Nicolino Ruperto, Elena Palmisani, et al.. (2013). Assessment of Radiographic Progression in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab: 2-Year Results From the TENDER Trial. UCL Discovery (University College London). 65. 1 indexed citations
17.
Buonuomo, Paola Sabrina, Claudia Bracaglia, Andrea Campana, et al.. (2009). Relapsing polychondritis: new therapeutic strategies with biological agents. Rheumatology International. 30(5). 691–693. 20 indexed citations
18.
Benedetti, Fabrizio De. (2009). Targeting interleukin-6 in pediatric rheumatic diseases. Current Opinion in Rheumatology. 21(5). 533–537. 29 indexed citations
19.
Massa, Margherita, Patrizia Pignatti, Fabrizio De Benedetti, et al.. (2002). Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein‐Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis & Rheumatism. 46(10). 2721–2729. 48 indexed citations
20.
Benedetti, Fabrizio De, et al.. (1995). Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis.. PubMed. 13(6). 779–84. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rolando Cimaz Breakdown of academic impact, for papers by Akihiro Yachie Breakdown of academic impact, for papers by Norihiro Nishimoto Breakdown of academic impact, for papers by Kazuyuki Yoshizaki Breakdown of academic impact, for papers by Naoyuki Kamatani Breakdown of academic impact, for papers by Donato Rigante Breakdown of academic impact, for papers by Pål Aukrust Breakdown of academic impact, for papers by Thor Ueland Breakdown of academic impact, for papers by Luca Cantarini Breakdown of academic impact, for papers by Guido Valesini
Rankless by CCL
2026